183 related articles for article (PubMed ID: 22676063)
41. Comparison of diagnostic tests for hymenoptera sting allergy.
Santrach PJ; Peterson LG; Yunginger JW
Ann Allergy; 1980 Sep; 45(3):130-36. PubMed ID: 6158280
[TBL] [Abstract][Full Text] [Related]
42. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G
J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512
[No Abstract] [Full Text] [Related]
43. [The basophil degranulation test in the diagnosis of Hymenoptera sting allergy].
Wüthrich B; Dietschi R; Berlinger F; Marti-Wyss S; Cuhat J
Schweiz Med Wochenschr; 1987 Sep; 117(36):1333-41. PubMed ID: 2443966
[TBL] [Abstract][Full Text] [Related]
44. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy.
Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F
Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111
[TBL] [Abstract][Full Text] [Related]
45. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
46. Clinical use of basophil activation test in drug, food and hymenoptera venom allergies.
De Amici M; Barocci F; Caimmi S; Nespoli L; Licari A; Giuliani G; Marseglia G
Minerva Pediatr; 2019 Apr; 71(2):209-217. PubMed ID: 30299021
[TBL] [Abstract][Full Text] [Related]
47. Insect sting allergy and venom immunotherapy: a model and a mystery.
Golden DB
J Allergy Clin Immunol; 2005 Mar; 115(3):439-47; quiz 448. PubMed ID: 15753884
[TBL] [Abstract][Full Text] [Related]
48. [Mastocytosis: an important differential diagnosis in anaphylactoid reaction to Hymenoptera sting. A case report and overview of clinical aspects, diagnosis and current therapy of mastocytosis].
Bucher C; Simic P; Furrer J; Wüthrich B
Praxis (Bern 1994); 2000 Mar; 89(10):411-8. PubMed ID: 10731856
[TBL] [Abstract][Full Text] [Related]
49. Insect anaphylaxis: addressing clinical challenges.
Tracy JM; Lewis EJ; Demain JG
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):332-6. PubMed ID: 21659864
[TBL] [Abstract][Full Text] [Related]
50. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
[TBL] [Abstract][Full Text] [Related]
51. Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy.
Bidad K; Nawijn MC; van Oosterhout AJ; van der Heide S; Elberink JN
Cytometry B Clin Cytom; 2014 May; 86(3):183-90. PubMed ID: 24478037
[TBL] [Abstract][Full Text] [Related]
52. [The basophil degranulation test in the diagnosis of bee and wasp sting allergies].
Mumcuoglu Y; Wortmann F
Schweiz Med Wochenschr; 1979 Aug; 109(32):1183-7. PubMed ID: 493908
[TBL] [Abstract][Full Text] [Related]
53. Basophil activation test for the diagnosis of hymenoptera venom allergy in childhood: a pilot study.
Ott H; Tenbrock K; Baron J; Merk H; Lehmann S
Klin Padiatr; 2011 Jan; 223(1):27-32. PubMed ID: 21271515
[TBL] [Abstract][Full Text] [Related]
54. Natural history of Hymenoptera venom allergy in Eastern Spain.
Fernandez J; Soriano V; Mayorga L; Mayor M
Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
[TBL] [Abstract][Full Text] [Related]
55. Venom immunotherapy reduces large local reactions to insect stings.
Golden DB; Kelly D; Hamilton RG; Craig TJ
J Allergy Clin Immunol; 2009 Jun; 123(6):1371-5. PubMed ID: 19443022
[TBL] [Abstract][Full Text] [Related]
56. Expression of activation markers on basophils in a controlled model of anaphylaxis.
Gober LM; Eckman JA; Sterba PM; Vasagar K; Schroeder JT; Golden DB; Saini SS
J Allergy Clin Immunol; 2007 May; 119(5):1181-8. PubMed ID: 17335884
[TBL] [Abstract][Full Text] [Related]
57. Reproducibility of skin testing and serum venom specific IgE in Hymenoptera venom allergy.
Graif Y; Confino-Cohen R; Goldberg A
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):24-9. PubMed ID: 16440528
[TBL] [Abstract][Full Text] [Related]
58. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
[TBL] [Abstract][Full Text] [Related]
59. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
60. [Side effects of specific immunotherapy in patients with hymenoptera venom allergy].
Lata J; Specjalski K; Kołaczkowska M; Chełmińska M; Niedoszytko M; Jassem E
Pneumonol Alergol Pol; 2005; 73(3):260-3. PubMed ID: 16989163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
